Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Charles Steven Schasteen"'
Publikováno v:
Journal of Controlled Release. 21:49-62
A major obstacle in the development of many new pharmaceuticals, particularly proteins and peptides, is their absorption across the small intestine mucosal barrier. We have developed a cell culture screen to discover novel compounds that increase the
Publikováno v:
Pharmacology. 42:156-168
The human intestinal cell line, Caco-2, and the Ca2+ ionophores, A23187 and ionomycin, were used to determine the interrelationships of 45Ca2+ efflux, transepithelial
Autor:
Janet C. Mayden, Charles Steven Schasteen, Rory F. Finn, George Irvin Glover, Sharon A. McLafferty, Lea D. Bullock, R. Paul Levine
Publikováno v:
Molecular Immunology. 28:17-26
Synthetic peptides based on functionally equivalent (as defined by similar patterns of chemically equivalent amino acids) serine protease inhibitor (serpin) C-terminal sequences inhibit both classical and alternative pathways of complement activation
Publikováno v:
Pharmaceutical Research. :210-216
The Caco-2 cell culture model of human small intestinal absorptive cells was used to investigate transepithelial transport. Transport of permeability markers such as mannitol demonstrated that Caco-2 monolayers became less permeable with increasing a
Publikováno v:
Journal of Controlled Release. 13:314-315
Publikováno v:
Molecular Immunology. 25:1261-1267
Sequence homology comparisons between serum serine protease inhibitors led to the prediction that the C-terminal sequences are functionally equivalent and represent an essential protease binding domain. Inhibition of complement serine protease D clea
Autor:
Charles Steven Schasteen, George Irvin Glover, Janet C. Mayden, Sharon A. McLafferty, R. Paul Levine, Wu-Schyong Liu, C.Y. Han
Publikováno v:
Molecular immunology. 25(12)
Synthetic peptides based on the amino acid sequence at the site of cleavage of C3 by classical and alternative pathway convertases were found to be poor inhibitors of hemolysis except at concns of 1 m M and higher. Synthetic peptides of a second type